BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases.

Razieh Amini Shadi Moradi Rezvan Najafi Mehrdokht Mazdeh Amir Taherkhani

Published in: Oxidative medicine and cellular longevity (2024)

The findings propose that ponciretin, danthron, chrysophanol, and N-p-coumaroyltyramine might serve as potential choices for the treatment of AD and PD, laying the groundwork for the creation of innovative BACE1 inhibitors.

Keyphrases

combination therapy
risk assessment
big data
heat stress
mild cognitive impairment